Abstract
The objective of this study was to develop pH-sensitive Eudragit L100–cysteine/reduced glutathione (Eul–cys/GSH) nanoparticles (NPs), which provided the mucoadhesion and protection for protein drugs against enzymatic degradation. Insulin was chosen as a model biomolecule for testing this system. The Eul–cys conjugate, which was obtained by grafting cysteine onto the carboxy group of Eudragit L100, was analyzed by HNMR and SEM, and the swelling degree (SD), cation binding, and enzymatic inhibition were also determined. The results obtained showed that the Eul–cys conjugate represent a pH-sensitive delivery system which effectively protected the insulin from being degraded by the proteases, and this is related to the mechanism of Ca2+ binding. Insulin-loaded Eul–cys/GSH NPs were prepared by a diffusion method involving an electrostatic interaction between the network structure of the polymer and the embedded proteins, including insulin and GSH. TEM images indicated that Eul–cys/GSH existed as smooth and spherical NPs in aqueous solution with particle sizes of 260 ± 20 nm. The X-ray diffraction (XRD) and X-ray photoelectron spectroscopy (XPS) findings showed the presence of amorphous insulin in thiolated NPs and higher free thiol oxidation than the result obtained by Ellman’s reagent method. In addition, thiolated NPs showed excellent binding efficiency to the mucin in rat intestine, indicating that Eul–cys/GSH NPs have great potential to be applied as safe carriers for the oral administration of protein drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andreani T, Luiza A, Souto EB et al (2014) Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery. Int J Pharm 473:627–635
Bakhru SH, Furtado S, Mathiowitz E et al (2013) Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev 65:811–821
Bernkop-Schnürch A (2005) Mucoadhesive polymers: strategies, achievements and future challenges. Adv Drug Deliv Rev 57:1553–1555
Bernkop-Schnürch A, Freudl A (1999) Comparative in vitro study of different chitosan-complexing agent conjugates. Pharmazie 54:369–371
Bernkop-Schnürch A, Krajicek ME (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Controlled Release 50:215–223
Bernkop-Schnürch A, Zarti H, Walker GF (2001) Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase N. J Pharm Sci 90:1907–1914
Bravo-Osuna I, Millotti G, Vauthier C et al (2007) In vitro evaluation of calcium-binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles. Int J Pharm 338:284–290
Chickering DE, Mathiowitz E (1995) Bioadhesive microspheres: I. A novel electrobalance-based method to study adhesive interactions between individual microspheres and intestinal mucosa. J Controlled Release 34:251–262
Felber AE, Dufresne MH, Leroux JC (2012) pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 64:979–992
Ganta S, Devalapally H, Amiji M et al (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. J Controlled Release 126:187–204
Herrero-Vanrell R, Rincón AC, Rodríguez-Cabello JC et al (2005) Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release. J Controlled Release 102:113–122
Jin Y, Song Y, Huang Y et al (2012) Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33:1573–1582
Kim BG, Kang IJ (2008) Evaluation of the effects of biodegradable nanoparticles on a vaccine delivery system using AFM, SEM and TEM. Ultramicroscopy 108:1168–1173
Luessen HL, Verhoef JC, Junginger HE et al (1995) Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res 12:1293–1298
Luessen HL, de Leeuw BJ, Junginger HE et al (1996) Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res 13:1668–1672
Mao S, Bakowsky U, Kissel T et al (2006) Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 95:1035–1048
Mukhopadhyay P, Sarkar K, Kundu PP et al (2013) Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model. Mater Sci Eng C 33:376–382
Pawar H, Douroumis D, Boateng JS (2012) Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery. Colloids Surf B 90:102–108
Ponchel G, Irache JM (1998) Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 34:191–219
Schmitz T, Grabovac V, Bernkop-Schnürch A et al (2008) Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate. Int J Pharm 347:79–85
Su FY, Lin KJ, Sung HW et al (2012) Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 33:2801–2811
Tiyaboonchai W, Woiszwillo J, Middaugh CR et al (2003) Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm 255:139–151
Torchilin V (2008) Intracellular delivery of protein and peptide therapeutics. Drug Discov Today 5:e95–e103
Vauthier C, Dubernet C, Couvreur P et al (2003) Drug delivery to resistant tumors: the potential of poly (alkyl cyanoacrylate) nanoparticles. J Controlled Release 93:151–160
Wee S, Gombotz WR (1998) Protein release from alginate matrices. Adv Drug Deliv Rev 31:267–285
Yamagata T, Morishita M, Peppas NA et al (2006) Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J Controlled Release 112:343–349
Yin L, Ding J, Yin C et al (2010) Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin. Biomaterials 31:3347–3356
Zhang Y, Wu X, Tang X et al (2012) Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Int J Pharm 436:341–350
Zhang Y, Du X, Tang X et al (2014) Thiolated Eudragit based nanoparticles for oral insulin delivery: preparation, characterization, and evaluation using intestinal epithelial cells in vitro. Macromol Biosci 14:842–852
Acknowledgments
The authors would like to acknowledge the financial support from the National Natural Science Foundation of China (No. 81202482).
Conflict of interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Y., Yang, Z., Hu, X. et al. Development and evaluation of mucoadhesive nanoparticles based on thiolated Eudragit for oral delivery of protein drugs. J Nanopart Res 17, 98 (2015). https://doi.org/10.1007/s11051-015-2909-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-015-2909-5